Announcement of TTY Biopharm's unaudited income information in January 2024

2024.2.16

Provided by: TTY BIOPHARM COMPANY LIMITED
SEQ_NO 1 Date of announcement 2024/02/16 Time of announcement 13:33:56
Subject Announcement of TTY Biopharm's unaudited income information in January 2024
Date of events 2024/02/16 To which item it meets paragraph 53
Statement 1.Date of occurrence of the event:2024/02/16
2.Company name:TTY Biopharm Co., Ltd.
3.Relationship to the Company (please enter ”head office” or ”subsidiaries”):Head office
4.Reciprocal shareholding ratios:N/A
5.Cause of occurrence:TTY Biopharm posted a consolidated net sales of $601,345 thousands (expressed in NT dollars; unaudited), a consolidated operating profit of $223,400 thousands, and a consolidated income before tax of $241,879 thousands in January 2024; net income attributed to stockholders of the company was $177,065 thousands; EPS is $0.71.
6.Countermeasures:None.
7.Any other matters that need to be specified (the information disclosure also meets the requirements of Article 7, subparagraph 9 of the Securities and Exchange Act Enforcement Rules, which brings forth a significant impact on shareholders rights or the price of the securities on public companies.):
The numbers above are unaudited. In term of the final net sales and profits, quarterly financial reports audited by independent accountants will prevail.
TOP